Chris became president and CEO of Versiti on Feb. 1, 2017, after a 20+ year career exclusively in healthcare. He is first and foremost a patient and donor advocate, while also passionate about the employee experience of 2,200 Versiti colleagues across multiple states. Chris and his leadership team have built a One Versiti culture, stoked the flame of innovation both organically and inorganically, invested in infrastructure, established Ohio as a fifth Versiti state, and led the organization to well over $400M in annual revenue.

Prior to joining Versiti, Chris served as group vice president and global immunology franchise head at Shire, helping to bring medicine to patients around the world and shaping the strategy for a $2.5 billion biopharmaceutical franchise. In his previous role at Baxalta, he was vice president of plasma strategy and new product development. Chris also worked for Baxter International as vice president of U.S. bioscience national accounts and spent 17 years with Eli Lilly and Company, most recently as general manager of their Australia and New Zealand operation.

Chris earned a Master of Business Administration from Harvard Business School in 2000 and a bachelor’s degree in accounting from Butler University in 1996. He was also a three-year starter on Butler’s basketball team and named an Academic All-American in 1995.

In June 2021, Chris joined the Butler University Board of Trustees. He was also appointed to the Board of Directors of Arthur J. Gallagher & Co. (NYSE: AJG) in March 2020, becoming the Governance committee chair in 2023; and was elected to the Medical College of Wisconsin Board in 2018.

Chris and his wife Nicole live in Whitefish Bay, WI, and stay busy with their three children Sage, Mace and Crew.